Natural polyphenols and cardioprotection

Mini-Reviews in Medicinal Chemistry

Volumn 11, Issue 14, 2011, Pages 1191-1199

  Lecour, S ^a   Lamont, K T ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cardioprotection; Cocoa; Natural polyphenols; Prosurvival signaling pathways; Tea wine

Indexed keywords

ALPHA TOCOPHEROL; ANTHOCYANIN; ANTIFIBROTIC AGENT; APOLIPOPROTEIN B; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; ASCORBIC ACID; BLACK TEA EXTRACT; CATECHIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIN 1; FLAVONOID; GLUCAGON LIKE PEPTIDE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA; MYELOPEROXIDASE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; POLYPHENOL DERIVATIVE; POMEGRANATE EXTRACT; QUERCETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RESVERATROL; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN; THEAFLAVIN; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; HEART PROTECTION; HUMAN; HYPOCHOLESTEROLEMIA; INFLAMMATION; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; POMEGRANATE JUICE; REPERFUSION INJURY; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; VASODILATATION;

EID: 82955214598     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955711804586766     Document Type: Article

References (123)

1. Maher, D.; Smeeth, L.; Sekajugo, J. Health transition in Africa:practical policy proposals for primary care. Bull World HealthOrgan, 2010, 88(12), 943-948.
2. Eaton, S.; Eaton, S. Evolution, diet and health. http://cast.uark.edu/local/icaes/conferences/wburg/posters/sboydeaton/eaton.htm (Accessed May 2011). 1997.
3. Renaud, S.; de Lorgeril, M. Wine, alcohol, platelets, and the Frenchparadox for coronary heart disease. Lancet, 1992, 339(8808), 1523-1526.
4. Mukamal, K.J.; Maclure, M.; Muller, J.E.; Sherwood, J.B.;Mittleman, M.A. Tea consumption and mortality after acutemyocardial infarction. Circulation, 2002, 105(21), 2476-2481.
5. McCullough, M.L.; Chevaux, K.; Jackson, L.; Preston, M.;Martinez, G.; Schmitz, H.H.; Coletti, C.; Campos, H.; Hollenberg, N.K. Hypertension, the Kuna, and the epidemiology of flavanols. J. Cardiovasc. Pharmacol., 2006, 47 Suppl 2, S103-109; discussion119-121.
6. Khan, N.; Monagas, M.; Andres-Lacueva, C.; Casas, R.; Urpi-Sarda, M.; Lamuela-Raventos, R.M.; Estruch, R. Regularconsumption of cocoa powder with milk increases HDL cholesteroland reduces oxidized LDL levels in subjects at high-risk ofcardiovascular disease. Nutr. Metab. Cardiovasc. Dis., 2011, inpress.
7. Wu, J.N.; Ho, S.C.; Zhou, C.; Ling, W.H.; Chen, W.Q.; Wang, C.L.; Chen, Y.M. Coffee consumption and risk of coronary heartdiseases: a meta-analysis of 21 prospective cohort studies. Int. J. Cardiol., 2009, 137(3), 216-225.
8. Oak, M.H.; El Bedoui, J.; Anglard, P.; Schini-Kerth, V.B. Redwine polyphenolic compounds strongly inhibit pro-matrixmetalloproteinase-2 expression and its activation in response tothrombin via, direct inhibition of membrane type 1-matrixmetalloproteinase in vascular smooth muscle cells. Circulation, 2004, 110(13), 1861-1867.
9. Sarr, M.; Chataigneau, M.; Martins, S.; Schott, C.; El Bedoui, J.;Oak, M.H.; Muller, B.; Chataigneau, T.; Schini-Kerth, V.B. Redwine polyphenols prevent angiotensin II-induced hypertension andendothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc Res., 2006, 71(4), 794-802.
10. Opie, L.H.; Lecour, S. The red wine hypothesis: from concepts toprotective signalling molecules. Eur. Heart J., 2007, 28(14), 1683-1693.
11. Sato, M.; Maulik, N.; Das, D.K. Cardioprotection with alcohol: roleof both alcohol and polyphenolic antioxidants. Ann. N Y Acad. Sci., 2002, 957, 122-135.
12. Hanasaki, Y.; Ogawa, S.; Fukui, S. The correlation between activeoxygens scavenging and antioxidative effects of flavonoids. FreeRadic. Biol. Med., 1994, 16(6), 845-850.
13. Santos, M.R.; Mira, L. Protection by flavonoids against theperoxynitrite-mediated oxidation of dihydrorhodamine. Free Radic. Res., 2004, 38(9), 1011-1018.
14. Fernandez, M.T.; Mira, M.L.; Florencio, M.H.; Jennings, K.R. Ironand copper chelation by flavonoids: an electrospray massspectrometry study. J. Inorg. Biochem., 2002, 92(2), 105-111.
15. Kostyuk, V.A.; Kraemer, T.; Sies, H.; Schewe, T. Myeloperoxidase/nitrite-mediated lipid peroxidation of low-densitylipoprotein as modulated by flavonoids. FEBS Lett., 2003, 537(1-3), 146-150.
16. Bagchi, D.; Sen, C.K.; Ray, S.D.; Das, D.K.; Bagchi, M.; Preuss, H.G.; Vinson, J.A. Molecular mechanisms of cardioprotection by anovel grape seed proanthocyanidin extract. Mutat. Res., 2003, 523-524, 87-97.
17. Al-Awwadi, N.A.; Araiz, C.; Bornet, A.; Delbosc, S.; Cristol, J.P.;Linck, N.; Azay, J.; Teissedre, P.L.; Cros, G. Extracts enriched indifferent polyphenolic families normalize increased cardiacNADPH oxidase expression while having differential effects oninsulin resistance, hypertension, and cardiac hypertrophy in highfructose-fed rats. J. Agric. Food Chem., 2005, 53(1), 151-157.
18. Lazze, M.C.; Pizzala, R.; Perucca, P.; Cazzalini, O.; Savio, M.;Forti, L.; Vannini, V.; Bianchi, L. Anthocyanidins decreaseendothelin-1 production and increase endothelial nitric oxidesynthase in human endothelial cells. Mol. Nutr. Food Res., 2006, 50(1), 44-51.
19. Kimura, Y.; Ito, H.; Ohnishi, R.; Hatano, T. Inhibitory effects ofpolyphenols on human cytochrome P450 3A4 and 2C9 activity. Food Chem. Toxicol., 2011, 48(1), 429-435.
20. Bhat, K.P.L.; Kosmeder, J.W., 2nd; Pezzuto, J.M. Biologicaleffects of resveratrol. Antioxid Redox Signal., 2001, 3(6), 1041-1064.
21. Csiszar, A.; Labinskyy, N.; Podlutsky, A.; Kaminski, P.M.; Wolin, M.S.; Zhang, C.; Mukhopadhyay, P.; Pacher, P.; Hu, F.; de Cabo, R.; Ballabh, P.; Ungvari, Z. Vasoprotective effects of resveratroland SIRT1: attenuation of cigarette smoke-induced oxidative stressand proinflammatory phenotypic alterations. Am. J. Physiol. HeartCirc. Physiol., 2008, 294(6), H2721-2735.
22. Leonard, S.S.; Xia, C.; Jiang, B.H.; Stinefelt, B.; Klandorf, H.;Harris, G.K.; Shi, X. Resveratrol scavenges reactive oxygenspecies and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun., 2003, 309(4), 1017-1026.
23. Shinmura, K.; Tamaki, K.; Sano, M.; Nakashima-Kamimura, N.;Wolf, A.M.; Amo, T.; Ohta, S.; Katsumata, Y.; Fukuda, K.;Ishiwata, K.; Suematsu, M.; Takeshi, A. Caloric Restriction PrimesMitochondria for Ischemic Stress by Deacetylating SpecificMitochondrial Proteins of the Electron Transport Chain. Circ. Res., 2011, 109, in press.
24. Faller, A.L.K.; Fialho, E. Polyphenol content and antioxidantcapacity in organic and conventional plant food. J. Food Comp. Anal., 2010, 23, 561-568.
25. Osakabe, N.; Yasuda, A.; Natsume, M.; Takizawa, T.; Terao, J.;Kondo, K. Catechins and their oligomers linked by C4--> C8bonds are major cacao polyphenols and protect low-densitylipoprotein from oxidation in vitro. Exp. Biol. Med., (Maywood)2002, 227(1), 51-56.
26. Rein, D.; Lotito, S.; Holt, R.R.; Keen, C.L.; Schmitz, H.H.; Fraga, C.G. Epicatechin in human plasma: in vivo, determination andeffect of chocolate consumption on plasma oxidation status. J. Nutr., 2000, 130(8S Suppl), 2109S-2114S.
27. Fuhrman, B.; Volkova, N.; Coleman, R.; Aviram, M. Grapepowder polyphenols attenuate atherosclerosis development inapolipoprotein E deficient (E0) mice and reduce macrophageatherogenicity. J. Nutr., 2005, 135(4), 722-728.
28. Davies, M.J.; Judd, J.T.; Baer, D.J.; Clevidence, B.A.; Paul, D.R.;Edwards, A.J.; Wiseman, S.A.; Muesing, R.A.; Chen, S.C. Blacktea consumption reduces total and LDL cholesterol in mildlyhypercholesterolemic adults. J. Nutr., 2003, 133(10), 3298S-3302S.
29. Aviram, M.; Dornfeld, L.; Rosenblat, M.; Volkova, N.; Kaplan, M.;Coleman, R.; Hayek, T.; Presser, D.; Fuhrman, B. Pomegranatejuice consumption reduces oxidative stress, atherogenicmodifications to LDL, and platelet aggregation: studies in humansand in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr., 2000, 71(5), 1062-1076.
30. Aviram, M.; Billecke, S.; Sorenson, R.; Bisgaier, C.; Newton, R.;Rosenblat, M.; Erogul, J.; Hsu, C.; Dunlop, C.; La Du, B. Paraoxonase active site required for protection against LDLoxidation involves its free sulfhydryl group and is different fromthat required for its arylesterase/paraoxonase activities: selectiveaction of human paraoxonase allozymes Q and R. ArteriosclerThromb. Vasc. Biol., 1998, 18(10), 1617-1624.
31. Aviram, M.; Rosenblat, M.; Bisgaier, C.L.; Newton, R.S.; Primo-Parmo, S.L.; La Du, B.N. Paraoxonase inhibits high-densitylipoprotein oxidation and preserves its functions. A possibleperoxidative role for paraoxonase. J. Clin. Invest., 1998, 101(8), 1581-1590.
32. Yasuda, A.; Natsume, M.; Osakabe, N.; Kawahata, K.; Koga, J. Cacao polyphenols influence the regulation of apolipoprotein inHepG2 and Caco2 cells. J. Agric. Food Chem., 2011, 59(4), 1470-1476.
33. Loest, H.B.; Noh, S.K.; Koo, S.I. Green tea extract inhibits thelymphatic absorption of cholesterol and alpha-tocopherol inovariectomized rats. J. Nutr., 2002, 132(6), 1282-1288.
34. Zern, T.L.; West, K.L.; Fernandez, M.L. Grape polyphenolsdecrease plasma triglycerides and cholesterol accumulation in theaorta of ovariectomized guinea pigs. J. Nutr., 2003, 133(7), 2268-2272.
35. Nishizuka, T.; Fujita, Y.; Sato, Y.; Nakano, A.; Kakino, A.;Ohshima, S.; Kanda, T.; Yoshimoto, R.; Sawamura, T. Procyanidins are potent inhibitors of LOX-1: a new player in theFrench Paradox. Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci., 2011, 87(3), 104-113.
36. Libby, P. Inflammation in atherosclerosis. Nature, 2002, 420(6917), 868-874.
37. Monagas, M.; Khan, N.; Andres-Lacueva, C.; Casas, R.; Urpi-Sarda, M.; Llorach, R.; Lamuela-Raventos, R.M.; Estruch, R. Effect of cocoa powder on the modulation of inflammatorybiomarkers in patients at high risk of cardiovascular disease. Am. J. Clin. Nutr., 2009, 90(5), 1144-1150.
38. Estruch, R.; Sacanella, E.; Badia, E.; Antunez, E.; Nicolas, J.M.;Fernandez-Sola, J.; Rotilio, D.; de Gaetano, G.; Rubin, E.; Urbano-Marquez, A. Different effects of red wine and gin consumption oninflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis, 2004, 175(1), 117-123.
39. Hodgson, J.M.; Puddey, I.B.; Mori, T.A.; Burke, V.; Baker, R.I.;Beilin, L.J. Effects of regular ingestion of black tea on haemostasisand cell adhesion molecules in humans. Eur. J. Clin. Nutr., 2001, 55(10), 881-886.
40. Murase, T.; Kume, N.; Hase, T.; Shibuya, Y.; Nishizawa, Y.;Tokimitsu, I.; Kita, T. Gallates inhibit cytokine-induced nucleartranslocation of NF-kappaB and expression of leukocyte adhesionmolecules in vascular endothelial cells. Arterioscler. Thromb Vasc. Biol., 1999, 19(6), 1412-1420.
41. Relja, B.; Tottel, E.; Breig, L.; Henrich, D.; Schneider, H.; Marzi, I.; Lehnert, M. Plant polyphenols attenuate hepatic injury afterhemorrhage/resuscitation by inhibition of apoptosis, oxidativestress, and inflammation via, NF-kappaB in rats. Eur. J. Nutr., 2011, in press.
42. Nijveldt, R.J.; van Nood, E.; van Hoorn, D.E.; Boelens, P.G.; van Norren, K.; van Leeuwen, P.A. Flavonoids: a review of probablemechanisms of action and potential applications. Am. J. Clin. Nutr., 2001, 74(4), 418-425.
43. Zykova, T.A.; Zhu, F.; Zhai, X.; Ma, W.Y.; Ermakova, S.P.; Lee, K.W.; Bode, A.M.; Dong, Z. Resveratrol directly targets COX-2 toinhibit carcinogenesis. Mol. Carcinog., 2008, 47(10), 797-805.
44. Loke, W.M.; Proudfoot, J.M.; Stewart, S.; McKinley, A.J.; Needs, P.W.; Kroon, P.A.; Hodgson, J.M.; Croft, K.D. Metabolictransformation has a profound effect on anti-inflammatory activityof flavonoids such as quercetin: lack of association betweenantioxidant and lipoxygenase inhibitory activity. Biochem. Pharmacol., 2008, 75(5), 1045-1053.
45. Demrow, H.S.; Slane, P.R.; Folts, J.D. Administration of wine andgrape juice inhibits in vivo, platelet activity and thrombosis instenosed canine coronary arteries. Circulation, 1995, 91(4), 1182-1188.
46. Freedman, J.E.; Parker, C., 3rd; Li, L.; Perlman, J.A.; Frei, B.;Ivanov, V.; Deak, L.R.; Iafrati, M.D.; Folts, J.D. Select flavonoidsand whole juice from purple grapes inhibit platelet function andenhance nitric oxide release. Circulation, 2001, 103(23), 2792-2798.
47. Vitseva, O.; Varghese, S.; Chakrabarti, S.; Folts, J.D.; Freedman, J.E. Grape seed and skin extracts inhibit platelet function andrelease of reactive oxygen intermediates. J Cardiovasc Pharmacol., 2005, 46(4), 445-451.
48. Di Santo, A.; Mezzetti, A.; Napoleone, E.; Di Tommaso, R.;Donati, M.B.; De Gaetano, G.; Lorenzet, R. Resveratrol andquercetin down-regulate tissue factor expression by humanstimulated vascular cells. J. Thromb. Haemost., 2003, 1(5), 1089-1095.
49. Dell'Agli, M.; Maschi, O.; Galli, G.V.; Fagnani, R.; Dal Cero, E.;Caruso, D.; Bosisio, E. Inhibition of platelet aggregation by oliveoil phenols via, cAMP-phosphodiesterase. Br. J. Nutr., 2008, 99(5), 945-951.
50. Widlansky, M.E.; Gokce, N.; Keaney, J.F., Jr.; Vita, J.A. Theclinical implications of endothelial dysfunction. J. Am. Coll. Cardiol., 2003, 42(7), 1149-1160.
51. Hirata, K.; Shimada, K.; Watanabe, H.; Otsuka, R.; Tokai, K.;Yoshiyama, M.; Homma, S.; Yoshikawa, J. Black tea increasescoronary flow velocity reserve in healthy male subjects. Am. J. Cardiol., 2004, 93(11), 1384-1388, A1386.
52. Stein, J.H.; Keevil, J.G.; Wiebe, D.A.; Aeschlimann, S.; Folts, J.D. Purple grape juice improves endothelial function and reduces thesusceptibility of LDL cholesterol to oxidation in patients withcoronary artery disease. Circulation, 1999, 100(10), 1050-1055.
53. Fischer, U.M.; Klass, O.; Stock, U.; Easo, J.; Geissler, H.J.;Fischer, J.H.; Bloch, W.; Mehlhorn, U. Cardioplegic arrest inducesapoptosis signal-pathway in myocardial endothelial cells andcardiac myocytes. Eur. J. Cardiothorac. Surg., 2003, 23(6), 984-990.
54. Hodgson, J.M. Effects of tea and tea flavonoids on endothelialfunction and blood pressure: a brief review. Clin. Exp. Pharmacol. Physiol., 2006, 33(9), 838-841.
55. Soares Filho, P.R.; Castro, I.; Stahlschmidt, A. Effect of red wineassociated with physical exercise in the cardiovascular system ofspontaneously hipertensive rats. Arq. Bras. Cardiol. 2011, 96(4), 277-283.
56. Leikert, J.F.; Rathel, T.R.; Wohlfart, P.; Cheynier, V.; Vollmar, A.M.; Dirsch, V.M. Red wine polyphenols enhance endothelialnitric oxide synthase expression and subsequent nitric oxide releasefrom endothelial cells. Circulation, 2002, 106(13), 1614-1617.
57. Lorenz, M.; Wessler, S.; Follmann, E.; Michaelis, W.; Dusterhoft, T.; Baumann, G.; Stangl, K.; Stangl, V. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxidesynthase by a phosphatidylinositol-3-OH-kinase-, cAMPdependentprotein kinase-, and Akt-dependent pathway and leads toendothelial-dependent vasorelaxation. J. Biol. Chem., 2004, 279(7), 6190-6195.
58. Wallerath, T.; Deckert, G.; Ternes, T.; Anderson, H.; Li, H.; Witte, K.; Forstermann, U. Resveratrol, a polyphenolic phytoalexinpresent in red wine, enhances expression and activity of endothelialnitric oxide synthase. Circulation, 2002, 106(13), 1652-1658.
59. Bhatt, S.R.; Lokhandwala, M.F.; Banday, A.A. Resveratrolprevents endothelial nitric oxide synthase uncoupling andattenuates development of hypertension in spontaneouslyhypertensive rats. Eur. J. Pharmacol., 2011, in press.
60. Imamura, G.; Bertelli, A.A.; Bertelli, A.; Otani, H.; Maulik, N.;Das, D.K. Pharmacological preconditioning with resveratrol: aninsight with iNOS knockout mice. Am. J. Physiol. Heart Circ., Physiol., 2002, 282(6), H1996-2003.
61. Dohadwala, M.M.; Holbrook, M.; Hamburg, N.M.; Shenouda, S.M.; Chung, W.B.; Titas, M.; Kluge, M.A.; Wang, N.; Palmisano, J.; Milbury, P.E.; Blumberg, J.B.; Vita, J.A. Effects of cranberryjuice consumption on vascular function in patients with coronaryartery disease. Am. J. Clin. Nutr., 2011, 93(5), 934-940.
62. Cassidy, A.; O'Reilly, E.J.; Kay, C.; Sampson, L.; Franz, M.;Forman, J.P.; Curhan, G.; Rimm, E.B. Habitual intake of flavonoidsubclasses and incident hypertension in adults. Am. J. Clin. Nutr., 2011, 93(2), 338-347.
63. Hodgson, J.M.; Puddey, I.B.; Burke, V.; Beilin, L.J.; Jordan, N. Effects on blood pressure of drinking green and black tea. J. Hypertens., 1999, 17(4), 457-463.
64. Yung, L.M.; Leung, F.P.; Wong, W.T.; Tian, X.Y.; Yung, L.H.;Chen, Z.Y.; Yao, X.Q.; Huang, Y. Tea polyphenols benefitvascular function. Inflammopharmacology, 2008, 16(5), 230-234.
65. Huang, Y.; Zhang, A.; Lau, C.W.; Chen, Z.Y. Vasorelaxant effectsof purified green tea epicatechin derivatives in rat mesentericartery. Life Sci., 1998, 63(4), 275-283.
66. Loke, W.M.; Hodgson, J.M.; Proudfoot, J.M.; McKinley, A.J.;Puddey, I.B.; Croft, K.D. Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1acutely in healthy men. Am. J. Clin. Nutr., 2008, 88(4), 1018-1025.
67. Akhlaghi, M.; Bandy, B. Mechanisms of flavonoid protectionagainst myocardial ischemia-reperfusion injury. J. Mol. CellCardiol., 2009, 46(3), 309-317.
68. Falchi, M.; Bertelli, A.; Lo Scalzo, R.; Morassut, M.; Morelli, R.;Das, S.; Cui, J.; Das, D.K. Comparison of cardioprotective abilitiesbetween the flesh and skin of grapes. J. Agric. Food Chem., 2006, 54(18), 6613-6622.
69. Hattori, R.; Otani, H.; Maulik, N.; Das, D.K. Pharmacologicalpreconditioning with resveratrol: role of nitric oxide. Am. J. Physiol. Heart Circ. Physiol., 2002, 282(6), H1988-1995.
70. Pataki, T.; Bak, I.; Kovacs, P.; Bagchi, D.; Das, D.K.; Tosaki, A. Grape seed proanthocyanidins improved cardiac recovery duringreperfusion after ischemia in isolated rat hearts. Am. J. Clin. Nutr., 2002, 75(5), 894-899.
71. Sato, M.; Maulik, G.; Ray, P.S.; Bagchi, D.; Das, D.K. Cardioprotective effects of grape seed proanthocyanidin againstischemic reperfusion injury. J. Mol. Cell Cardiol., 1999, 31(6), 1289-1297.
72. Gurusamy, N.; Ray, D.; Lekli, I.; Das, D.K. Red wine antioxidantresveratrol-modified cardiac stem cells regenerate infarctedmyocardium. J. Cell Mol. Med., 2010, 14(9), 2235-2239.
73. Song, D.K.; Jang, Y.; Kim, J.H.; Chun, K.J.; Lee, D.; Xu, Z. Polyphenol (-)-epigallocatechin gallate during ischemia limitsinfarct size via, mitochondrial K(ATP) channel activation inisolated rat hearts. J. Korean Med. Sci., 2010, 25(3), 380-386.
74. Panneerselvam, M.; Tsutsumi, Y.M.; Bonds, J.A.; Horikawa, Y.T.;Saldana, M.; Dalton, N.D.; Head, B.P.; Patel, P.M.; Roth, D.M.;Patel, H.H. Dark chocolate receptors: epicatechin-induced cardiacprotection is dependent on delta-opioid receptor stimulation. Am. J. Physiol. Heart Circ. Physiol., 2010, 299(5), H1604-1609.
75. Yamazaki, K.G.; Taub, P.R.; Barraza-Hidalgo, M.; Rivas, M.M.;Zambon, A.C.; Ceballos, G.; Villarreal, F.J. Effects of (-)-epicatechin on myocardial infarct size and left ventricularremodeling after permanent coronary occlusion. J. Am. Coll. Cardiol., 2010, 55(25), 2869-2876.
76. Yeh, E.T.; Tong, A.T.; Lenihan, D.J.; Yusuf, S.W.; Swafford, J.;Champion, C.; Durand, J.B.; Gibbs, H.; Zafarmand, A.A.; Ewer, M.S. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation, 2004, 109(25), 3122-3131.
77. Dresdale, A.R.; Barr, L.H.; Bonow, R.O.; Mathisen, D.J.; Myers, C.E.; Schwartz, D.E.; d'Angelo, T.; Rosenberg, S.A. Prospectiverandomized study of the role of N-acetyl cysteine in reversingdoxorubicin-induced cardiomyopathy. Am. J. Clin. Oncol., 1982, 5(6), 657-663.
78. Conklin, K.A. Coenzyme q10 for prevention of anthracyclineinducedcardiotoxicity. Integr. Cancer Ther., 2005, 4(2), 110-130.
79. Albini, A.; Pennesi, G.; Donatelli, F.; Cammarota, R.; De Flora, S.;Noonan, D.M. Cardiotoxicity of anticancer drugs: the need forcardio-oncology and cardio-oncological prevention. J. Natl. CancerInst., 2011, 102(1), 14-25.
80. Soucek, P.; Kondrova, E.; Hermanek, J.; Stopka, P.; Boumendjel, A.; Ueng, Y.F.; Gut, I. New model system for testing effects offlavonoids on doxorubicin-related formation of hydroxyl radicals. Anticancer Drugs, 2011, 22(2), 176-184.
81. Zhou, H.B.; Chen, J.J.; Wang, W.X.; Cai, J.T.; Du, Q. Anticanceractivity of resveratrol on implanted human primary gastriccarcinoma cells in nude mice. World J. Gastroenterol., 2005, 11(2), 280-284.
82. Baur, J.A.; Pearson, K.J.; Price, N.L.; Jamieson, H.A.; Lerin, C.;Kalra, A.; Prabhu, V.V.; Allard, J.S.; Lopez-Lluch, G.; Lewis, K.;Pistell, P.J.; Poosala, S.; Becker, K.G.; Boss, O.; Gwinn, D.; Wang, M.; Ramaswamy, S.; Fishbein, K.W.; Spencer, R.G.; Lakatta, E.G.;Le Couteur, D.; Shaw, R.J.; Navas, P.; Puigserver, P.; Ingram, D.K.; de Cabo, R.; Sinclair, D.A. Resveratrol improves health andsurvival of mice on a high-calorie diet. Nature, 2006, 444(7117), 337-342.
83. Hou, X.; Xu, S.; Maitland-Toolan, K.A.; Sato, K.; Jiang, B.; Ido, Y.; Lan, F.; Walsh, K.; Wierzbicki, M.; Verbeuren, T.J.; Cohen, R.A.; Zang, M. SIRT1 regulates hepatocyte lipid metabolismthrough activating AMP-activated protein kinase. J. Biol. Chem., 2008, 283(29), 20015-20026.
84. Hwang, J.T.; Kwon, D.Y.; Yoon, S.H. AMP-activated proteinkinase: a potential target for the diseases prevention by naturaloccurring polyphenols. N. Biotechnol., 2009, 26(1-2), 17-22.
85. Dao, T.M.; Waget, A.; Klopp, P.; Serino, M.; Vachoux, C.;Pechere, L.; Drucker, D.J.; Champion, S.; Barthelemy, S.; Barra, Y.; Burcelin, R.; Seree, E. Resveratrol Increases Glucose InducedGLP-1 Secretion in Mice: A Mechanism which Contributes to theGlycemic Control. PLoS One, 2011, 6(6), e20700.
86. Hausenloy, D.J.; Lecour, S.; Yellon, D.M. Reperfusion injurysalvage kinase and survivor activating factor enhancementprosurvival signaling pathways in ischemic postconditioning: twosides of the same coin. Antioxid Redox. Signal, 2011, 14(5), 893-907.
87. Thirunavukkarasu, M.; Penumathsa, S.V.; Samuel, S.M.; Akita, Y.;Zhan, L.; Bertelli, A.A.; Maulik, G.; Maulik, N. White wineinduced cardioprotection against ischemia-reperfusion injury ismediated by life extending Akt/FOXO3a/NFkappaB survivalpathway. J. Agric Food Chem., 2008, 56(15), 6733-6739.
88. Das, D.K.; Maulik, N. Resveratrol in cardioprotection: atherapeutic promise of alternative medicine. Mol. Interv., 2006, 6(1), 36-47.
89. Xi, J.; Wang, H.; Mueller, R.A.; Norfleet, E.A.; Xu, Z. Mechanismfor resveratrol-induced cardioprotection against reperfusion injuryinvolves glycogen synthase kinase 3beta and mitochondrialpermeability transition pore. Eur. J. Pharmacol., 2009, 604(1-3), 111-116.
90. Gurusamy, N.; Lekli, I.; Mukherjee, S.; Ray, D.; Ahsan, M.K.;Gherghiceanu, M.; Popescu, L.M.; Das, D.K. Cardioprotection byresveratrol: a novel mechanism via, autophagy involving themTORC2 pathway. Cardiovasc Res., 2010, 86(1), 103-112.
91. Lekli, I.; Ray, D.; Mukherjee, S.; Gurusamy, N.; Ahsan, M.K.;Juhasz, B.; Bak, I.; Tosaki, A.; Gherghiceanu, M.; Popescu, L.M.;Das, D.K. Co-ordinated autophagy with resveratrol and gammatocotrienolconfers synergetic cardioprotection. J. Cell Mol. Med., 2010, 14(10), 2506-2518.
92. Agrawal, M.; Kumar, V.; Kashyap, M.P.; Khanna, V.K.;Randhawa, G.S.; Pant, A.B. Ischemic insult induced apoptoticchanges in PC12 cells: Protection by trans resveratrol. Eur. J. Pharmacol., 2011, 666(1-3), 5-11.
93. Lacerda, L.; Somers, S.; Opie, L.H.; Lecour, S. Ischaemicpostconditioning protects against reperfusion injury via, the SAFEpathway. Cardiovasc. Res., 2009, 84(2), 201-208.
94. Lecour, S. Activation of the protective Survivor Activating FactorEnhancement (SAFE) pathway against reperfusion injury: Does itgo beyond the RISK pathway? J. Mol. Cell Cardiol., 2009, 47(1), 32-40.
95. Lamont, K.T.; Somers, S.; Lacerda, L.; Opie, L.H.; Lecour, S. Isred wine a SAFE sip away from cardioprotection? Mechanismsinvolved in resveratrol-and melatonin-induced cardioprotection. J. Pineal Res., 2011, 50(4), 374-380.
96. Deuchar, G.A.; Opie, L.H.; Lecour, S. TNFalpha is required toconfer protection in an in vivo, model of classical ischaemicpreconditioning. Life Sci., 2007, 80(18), 1686-1691.
97. Kelly, R.F.; Lamont, K.T.; Somers, S.; Hacking, D.; Lacerda, L.;Thomas, P.; Opie, L.H.; Lecour, S. Ethanolamine is a novel STAT-3 dependent cardioprotective agent. Basic Res. Cardiol., 2010, 105(6), 763-770.
98. Lecour, S.; Rochette, L.; Opie, L. Free radicals trigger TNF alphainducedcardioprotection. Cardiovasc. Res., 2005, 65(1), 239-243.
99. Lecour, S.; Suleman, N.; Deuchar, G.A.; Somers, S.; Lacerda, L.;Huisamen, B.; Opie, L.H. Pharmacological preconditioning withtumor necrosis factor-alpha activates signal transducer andactivator of transcription-3 at reperfusion without involving classicprosurvival kinases (Akt and extracellular signal-regulated kinase). Circulation, 2005, 112(25), 3911-3918.
100. Fuglesteg, B.N.; Suleman, N.; Tiron, C.; Kanhema, T.; Lacerda, L.;Andreasen, T.V.; Sack, M.N.; Jonassen, A.K.; Mjos, O.D.; Opie, L.H.; Lecour, S. Signal transducer and activator of transcription 3is involved in the cardioprotective signalling pathway activated byinsulin therapy at reperfusion. Basic Res. Cardiol., 2008, 103(5), 444-453.
101. Lacerda, L.; Somers, S.; Opie, L.; Lecour, S. Bradykinin, insulinand opioids mimic ischemic postconditioning. Cardiovasc. Res., 2010, 87, 126.
102. Lecour, S.; Smith, R.M.; Woodward, B.; Opie, L.H.; Rochette, L.;Sack, M.N. Identification of a novel role for sphingolipid signalingin TNF alpha and ischemic preconditioning mediatedcardioprotection. J. Mol. Cell Cardiol., 2002, 34(5), 509-518.
103. Boengler, K.; Hilfiker-Kleiner, D.; Heusch, G.; Schulz, R. Inhibition of permeability transition pore opening by mitochondrialSTAT3 and its role in myocardial ischemia/reperfusion. Basic Res. Cardiol., 2010, 105(6), 771-785.
104. Brunet, A.; Sweeney, L.B.; Sturgill, J.F.; Chua, K.F.; Greer, P.L.;Lin, Y.; Tran, H.; Ross, S.E.; Mostoslavsky, R.; Cohen, H.Y.; Hu, L.S.; Cheng, H.L.; Jedrychowski, M.P.; Gygi, S.P.; Sinclair, D.A.;Alt, F.W.; Greenberg, M.E. Stress-dependent regulation of FOXOtranscription factors by the SIRT1 deacetylase. Science, 2004, 303(5666), 2011-2015.
105. Xiong, S.; Salazar, G.; Patrushev, N.; Alexander, R.W. FoxO1mediates an autofeedback loop regulating SIRT1 expression. J. Biol. Chem., 2011, 286(7), 5289-5299.
106. Mukhopadhyay, P.; Mukherjee, S.; Ahsan, K.; Bagchi, A.; Pacher, P.; Das, D.K. Restoration of altered microRNA expression in theischemic heart with resveratrol. PLoS One, 2010, 5(12), e15705.
107. Mukhopadhyay, P.; Pacher, P.; Das, D.K. MicroRNA signatures ofresveratrol in the ischemic heart. Ann. N Y Acad. Sci., 2011, 1215, 109-116.
108. Dal-Ros, S.; Zoll, J.; Lang, A.L.; Auger, C.; Keller, N.; Bronner, C.; Geny, B.; Schini-Kerth, V.B. Chronic intake of red winepolyphenols by young rats prevents aging-induced endothelialdysfunction and decline in physical performance: role of NADPHoxidase. Biochem. Biophys. Res. Commun., 2011, 404(2), 743-749.
109. Cruz, M.N.; Luksha, L.; Logman, H.; Poston, L.; Agewall, S.;Kublickiene, K. Acute responses to phytoestrogens in small arteriesfrom men with coronary heart disease. Am. J. Physiol. Heart Circ. Physiol., 2006, 290(5), H1969-1975.
110. Pellegatta, F.; Bertelli, A.A.; Staels, B.; Duhem, C.; Fulgenzi, A.;Ferrero, M.E. Different short-and long-term effects of resveratrolon nuclear factor-kappaB phosphorylation and nuclear appearancein human endothelial cells. Am. J. Clin. Nutr., 2003, 77(5), 1220-1228.
111. Olson, E.R.; Naugle, J.E.; Zhang, X.; Bomser, J.A.; Meszaros, J.G. Inhibition of cardiac fibroblast proliferation and myofibroblastdifferentiation by resveratrol. Am. J. Physiol. Heart Circ. Physiol., 2005, 288(3), H1131-1138.
112. Baron-Menguy, C.; Bocquet, A.; Guihot, A.L.; Chappard, D.;Amiot, M.J.; Andriantsitohaina, R.; Loufrani, L.; Henrion, D. Effects of red wine polyphenols on postischemicneovascularization model in rats: low doses are proangiogenic, high doses anti-angiogenic. Faseb. J., 2007, 21(13), 3511-3521.
113. Vang, O.; Ahmad, N.; Baile, C.A.; Baur, J.A.; Brown, K.; Csiszar, A.; Das, D.K.; Delmas, D.; Gottfried, C.; Lin, H.Y.; Ma, Q.Y.;Mukhopadhyay, P.; Nalini, N.; Pezzuto, J.M.; Richard, T.; Shukla, Y.; Surh, Y.J.; Szekeres, T.; Szkudelski, T.; Walle, T.; Wu, J.M. What is new for an old molecule? Systematic review andrecommendations on the use of resveratrol. PLoS One, 2011, 6(6), e19881.
114. Wollgast, J.; Pallaroni, L.; Agazzi, M.E.; Anklam, E. Analysis ofprocyanidins in chocolate by reversed-phase high-performanceliquid chromatography with electrospray ionisation massspectrometric and tandem mass spectrometric detection. J. Chromatogr. A., 2001, 926(1), 211-220.
115. Mosca, L.; De Marco, C.; Visioli, F.; Cannella, C. Enzymatic assayfor the determination of olive oil polyphenol content: assay conditions and validation of the method. J. Agric. Food Chem., 2000, 48(2), 297-301.
116. Visioli, F.; Galli, C. The effect of minor constituents of olive oil oncardiovascular disease: new findings. Nutrition reviews, 2011, 56(5), 142-147.
117. Scalbert, A.; Williamson, G. Dietary intake and bioavailability of polyphenols. J. Nutr., 2000, 130(8S Suppl), 2073S-2085S.
118. Mursu, J.; Voutilainen, S.; Nurmi, T.; Tuomainen, T.P.; Kurl, S.;Salonen, J.T. Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br. J. Nutr., 2008, 100(4), 890-895.
119. Kim, J.A. Mechanisms underlying beneficial health effects of teacatechins to improve insulin resistance and endothelial dysfunction. Endocr. Metab. Immune Disord. Drug Targets., 2008, 8(2), 82-88.
120. Thielecke, F.; Boschmann, M. The potential role of green teacatechins in the prevention of the metabolic syndrome-a review. Phytochemistry, 2009, 70(1), 11-24.
121. Matsuyama, T.; Tanaka, Y.; Kamimaki, I.; Nagao, T.; Tokimitsu, I. Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Obesity (Silver Spring), 2008, 16(6), 1338-1348.
122. Szkudelski, T.; Szkudelska, K. Anti-diabetic effects of resveratrol. Ann. N Y Acad. Sci., 2011, 1215, 34-39.
123. Robich, M.P.; Osipov, R.M.; Nezafat, R.; Feng, J.; Clements, R.T.;Bianchi, C.; Boodhwani, M.; Coady, M.A.; Laham, R.J.; Sellke, F.W. Resveratrol improves myocardial perfusion in a swine modelof hypercholesterolemia and chronic myocardial ischemia. Circulation, 2010, 122(11 Suppl), S142-149.